Analystreport

Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $48.00 price target on the stock.

Celldex Therapeutics, Inc.  (CLDX) 
Last celldex therapeutics, inc. earnings: 11/12 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com